Filing Details
- Accession Number:
- 0001415889-24-026102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-05 15:04:53
- Reporting Period:
- 2024-11-01
- Accepted Time:
- 2024-11-05 15:04:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534133 | Calcimedica Inc. | CALC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1267959 | A Fred Middleton | C/O Calcimedica, Inc. 505 Coast Blvd. S. #307 La Jolla CA 92037 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-01 | 20,000 | $3.75 | 31,714 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-11-01 | 86,867 | $3.75 | 814,300 | No | 4 | P | Indirect | By Sanderling Venture Partners VI Co-Investment Fund, L.P. |
Common Stock | Acquisiton | 2024-11-01 | 877 | $3.75 | 22,479 | No | 4 | P | Indirect | By Sanderling Ventures Management VI |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | By Sanderling Venture Partners VI Co-Investment Fund, L.P. |
No | 4 | P | Indirect | By Sanderling Ventures Management VI |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 946,744 | Indirect | By Sanderling Venture Partners VI, LP |
Common Stock | 7,456 | Indirect | By Sanderling VI Beteligungs GmbH & Co KG |
Common Stock | 8,884 | Indirect | By Sanderling VI Limited Partnership |
Common Stock | 435,148 | Indirect | By Sanderling Ventures VII, L.P. |
Common Stock | 114,260 | Indirect | By Sanderling Ventures VII (Canada), L.P. |
Common Stock | 27,609 | Indirect | By Sanderling Ventures VII Annex Fund, L.P. |
Common Stock | 30,292 | Indirect | By Sanderling Ventures Management VII |
Common Stock | 8,176 | Indirect | By Golden Triangle Ventures, LLC |
Footnotes
- The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP ("SVP VI Co-Investment, LP", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VI Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP ("SVP VII, LP", together with Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), L.P. and Sanderling Ventures VII Annex Fund, L.P., the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VII Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.